$QSEP
QS Energy, Inc.

2024 Q4 Form 10-Q Financial Statement

#000168316824008065 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $48.00K
YoY Change 2.13%
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $48.00K
YoY Change 2.13%
Operating Profit -$279.0K
YoY Change 32.23%
Interest Expense -$86.00K
YoY Change -4.44%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$365.0K
YoY Change 21.67%
Income Tax
% Of Pretax Income
Net Earnings -$365.0K
YoY Change 21.26%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 420.9M shares 405.9M shares
Diluted Shares Outstanding 406.8M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $237.0K
YoY Change 12.86%
Cash & Equivalents $237.0K
Short-Term Investments
Other Short-Term Assets $12.00K
YoY Change -60.0%
Inventory
Prepaid Expenses $12.00K
Receivables
Other Receivables
Total Short-Term Assets $249.0K
YoY Change 4.18%
LONG-TERM ASSETS
Property, Plant & Equipment $1.000K
YoY Change -66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.000K
YoY Change -66.67%
TOTAL ASSETS
Total Short-Term Assets $249.0K
Total Long-Term Assets $1.000K
Total Assets $250.0K
YoY Change 3.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.374M
YoY Change 10.99%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.476M
YoY Change 12.04%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.802M
YoY Change 9.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.802M
Total Long-Term Liabilities $0.00
Total Liabilities $5.802M
YoY Change 9.82%
SHAREHOLDERS EQUITY
Retained Earnings -$126.5M
YoY Change 1.16%
Common Stock $410.6K
YoY Change 5.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.552M
YoY Change
Total Liabilities & Shareholders Equity $250.0K
YoY Change 3.31%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$365.0K
YoY Change 21.26%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$270.0K
YoY Change 42.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 375.0K
YoY Change 13.64%
NET CHANGE
Cash From Operating Activities -270.0K
Cash From Investing Activities
Cash From Financing Activities 375.0K
Net Change In Cash 105.0K
YoY Change -25.0%
FREE CASH FLOW
Cash From Operating Activities -$270.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001103795
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
410598209 shares
dei Document Type
DocumentType
10-Q
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84000 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
231000 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
164000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
758000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
508000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-301000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1147000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 qsep Common Stock Issued For Settlement Of Accounts Payable
CommonStockIssuedForSettlementOfAccountsPayable
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-29185
dei Entity Registrant Name
EntityRegistrantName
QS ENERGY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2088326
dei Entity Address Address Line1
EntityAddressAddressLine1
23902 FM 2978
dei Entity Address City Or Town
EntityAddressCityOrTown
Tomball
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77375
dei City Area Code
CityAreaCode
775
dei Local Phone Number
LocalPhoneNumber
300-7647
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
420902275 shares
CY2024Q3 us-gaap Cash
Cash
237000 usd
CY2023Q4 us-gaap Cash
Cash
70000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
249000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
82000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
101000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
99000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2000 usd
CY2024Q3 us-gaap Assets
Assets
250000 usd
CY2023Q4 us-gaap Assets
Assets
84000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2374000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2198000 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
952000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
972000 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2438000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2101000 usd
CY2024Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
38000 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
57000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5802000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5328000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
5802000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5328000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
410598209 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
392586471 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
392586471 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
410598 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
392587 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
120550402 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119729413 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-126513000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125366000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-5552000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5244000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
250000 usd
CY2024Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
45000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
45000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
148000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-279000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-211000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-901000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-656000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
86000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
90000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
246000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
263000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-365000 usd
us-gaap Net Income Loss
NetIncomeLoss
-919000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
406763985 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
406763985 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
386625687 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
386625687 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
399574212 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
399574212 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
383451584 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
383451584 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5542000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
98000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
234000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
23000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-365000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-5552000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5244000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
225000 usd
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
424000 usd
qsep Common Stock Issued For Settlement Of Accounts Payable
CommonStockIssuedForSettlementOfAccountsPayable
18000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
32000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
140000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1147000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-5552000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4979000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
83000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
128000 usd
CY2023Q3 qsep Common Stock Issued Upon Exercise Of Warrants
CommonStockIssuedUponExerciseOfWarrants
8000 usd
CY2023Q3 qsep Fair Value Of Options And Warrants Issued As Compensation
FairValueOfOptionsAndWarrantsIssuedAsCompensation
20000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-301000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5041000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4690000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
253000 usd
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
231000 usd
qsep Common Stock Issued Upon Exercise Of Warrants
CommonStockIssuedUponExerciseOfWarrants
50000 usd
qsep Fair Value Of Options And Warrants Issued As Compensation
FairValueOfOptionsAndWarrantsIssuedAsCompensation
34000 usd
us-gaap Net Income Loss
NetIncomeLoss
-919000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5041000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1147000 usd
us-gaap Net Income Loss
NetIncomeLoss
-919000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
32000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
34000 usd
qsep Fair Value Of Common Stock Issued As Compensation
FairValueOfCommonStockIssuedAsCompensation
18000 usd
qsep Fair Value Of Common Stock Issued As Compensation
FairValueOfCommonStockIssuedAsCompensation
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
140000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
50000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
90000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
160000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
137000 usd
us-gaap Depreciation
Depreciation
1000 usd
us-gaap Depreciation
Depreciation
3000 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-0 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-0 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
176000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
177000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-20000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-7000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-589000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-491000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
775000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
533000 usd
qsep Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
0 usd
qsep Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
50000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
19000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
11000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
756000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
572000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
167000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
81000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
214000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1600 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1600 usd
qsep Conversion Of Convertible Notes And Accrued Interest To Common Stock
ConversionOfConvertibleNotesAndAccruedInterestToCommonStock
255000 usd
qsep Conversion Of Convertible Notes And Accrued Interest To Common Stock
ConversionOfConvertibleNotesAndAccruedInterestToCommonStock
253000 usd
qsep Value Of Warrants Issued With Convertible Notes
ValueOfWarrantsIssuedWithConvertibleNotes
424000 usd
qsep Value Of Warrants Issued With Convertible Notes
ValueOfWarrantsIssuedWithConvertibleNotes
231000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1147000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-589000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-5552000 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
2287000 usd
CY2024Q3 us-gaap Cash
Cash
237000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_ztuL2gvDfV95" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_863_zd4wN3eaDHs7">Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accruals for potential liabilities, assumptions used in valuing equity instruments issued for financing and services and valuation allowance for deferred tax assets, among others. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
72661837 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
81212412 shares
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
148000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
CY2024Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1654000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1332000 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
954000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
794000 usd
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2608000 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2265000 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
170000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
25000 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2438000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2101000 usd
CY2024Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1654000 usd
us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
As of September 30, 2024, convertible notes payable and accrued interest are convertible into approximately 21,920,856 shares of common stock at conversion rates ranging from $0.02 to $0.48 per share.
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
49000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
148000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
qsep Common Stock Stock Issued For Settlement Of Accounts Payable
CommonStockStockIssuedForSettlementOfAccountsPayable
18000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-008065-index-headers.html Edgar Link pending
0001683168-24-008065-index.html Edgar Link pending
0001683168-24-008065.txt Edgar Link pending
0001683168-24-008065-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qsenergy_ex3101.htm Edgar Link pending
qsenergy_ex3102.htm Edgar Link pending
qsenergy_ex3200.htm Edgar Link pending
qsenergy_i10q-093024.htm Edgar Link pending
qsep-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
qsep-20240930_cal.xml Edgar Link unprocessable
qsenergy_i10q-093024_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
qsep-20240930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
qsep-20240930_pre.xml Edgar Link unprocessable
qsep-20240930_lab.xml Edgar Link unprocessable